Hamilton JR - Search Results

1

Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.

French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, Hamilton JR. French SL, et al. Among authors: hamilton jr. J Thromb Haemost. 2016 Aug;14(8):1642-54. doi: 10.1111/jth.13293. Epub 2016 Jun 22. J Thromb Haemost. 2016. PMID: 26878340 Free article.

2

Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.

Hamilton JR, Nguyen PB, Cocks TM. Hamilton JR, et al. Circ Res. 1998 Jun 29;82(12):1306-11. doi: 10.1161/01.res.82.12.1306. Circ Res. 1998. PMID: 9648727

3

Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.

Hamilton JR, Moffatt JD, Frauman AG, Cocks TM. Hamilton JR, et al. J Cardiovasc Pharmacol. 2001 Jul;38(1):108-19. doi: 10.1097/00005344-200107000-00012. J Cardiovasc Pharmacol. 2001. PMID: 11444493

4

Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.

Hamilton JR, Cornelissen I, Coughlin SR. Hamilton JR, et al. J Thromb Haemost. 2004 Aug;2(8):1429-35. doi: 10.1111/j.1538-7836.2004.00783.x. J Thromb Haemost. 2004. PMID: 15304051 Free article.

5

Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth.

Ono A, Westein E, Hsiao S, Nesbitt WS, Hamilton JR, Schoenwaelder SM, Jackson SP. Ono A, et al. Among authors: hamilton jr. Blood. 2008 Jul 1;112(1):90-9. doi: 10.1182/blood-2007-12-127001. Epub 2008 Feb 29. Blood. 2008. PMID: 18310501 Free article.

6

Protease-activated receptors as targets for antiplatelet therapy.

Hamilton JR. Hamilton JR. Blood Rev. 2009 Mar;23(2):61-5. doi: 10.1016/j.blre.2008.06.002. Epub 2008 Jul 21. Blood Rev. 2009. PMID: 18644663 Review.

7

Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.

Hamilton JR, Cornelissen I, Mountford JK, Coughlin SR. Hamilton JR, et al. Atherosclerosis. 2009 Aug;205(2):427-32. doi: 10.1016/j.atherosclerosis.2009.01.018. Epub 2009 Jan 23. Atherosclerosis. 2009. PMID: 19217621 Free PMC article.

8

The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.

Lee H, Sturgeon SA, Jackson SP, Hamilton JR. Lee H, et al. Among authors: hamilton jr. Thromb Haemost. 2012 Feb;107(2):328-37. doi: 10.1160/TH11-06-0418. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22187047

9

Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease.

Lee H, Hamilton JR. Lee H, et al. Among authors: hamilton jr. Pharmacol Ther. 2012 May;134(2):246-59. doi: 10.1016/j.pharmthera.2012.01.007. Epub 2012 Jan 30. Pharmacol Ther. 2012. PMID: 22327235 Review.

10

Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice.

Lee H, Sturgeon SA, Mountford JK, Jackson SP, Hamilton JR. Lee H, et al. Among authors: hamilton jr. Br J Pharmacol. 2012 Aug;166(7):2188-97. doi: 10.1111/j.1476-5381.2012.01944.x. Br J Pharmacol. 2012. PMID: 22428607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters